United States, Kansas — Manhattan, Kansas

United States, Kansas is a clinical research site located in Manhattan, Kansas, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

United States, Kansas has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB Biopharma S.P.R.L..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States, Kansas?

United States, Kansas has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States, Kansas conducted?

United States, Kansas has 1 clinical trials on record. Their work covers Epilepsy.

Is United States, Kansas accredited by Crixeo Health?

United States, Kansas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States, Kansas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.